Liberty Street Advisors, Inc. 23and Me Holding Co. Transaction History

Liberty Street Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$0.96 - $2.01 $96,000 - $200,999	-100,000 Reduced 21.09%	374,260 $366,000
Q2 2023 Jul 24, 2023	SELL	$1.59 - $2.29 $397,500 - $572,500	-250,000 Reduced 34.52%	474,260 $829,000
Q3 2022 Nov 02, 2022	SELL	$2.6 - $5.12 $260,000 - $512,000	-100,000 Reduced 12.13%	724,260 $2.07 Million
Q1 2022 Apr 26, 2022	SELL	$3.28 - $7.12 $164,000 - $356,000	-50,000 Reduced 5.72%	824,260 $3.16 Million
Q3 2021 Nov 10, 2021	BUY	$7.29 - $11.0 $654,036 - $986,887	89,717 Added 11.44%	874,260 $7.76 Million
Q2 2021 Aug 05, 2021	BUY	$9.87 - $13.32 $7.74 Million - $10.5 Million	784,543 New	784,543 $8.75 Million

116

82.6M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Liberty Street Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Liberty Street Advisors, Inc. with notifications on news.